Literature DB >> 14625544

Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.

Urs Eriksson1, Romeo Ricci, Lukas Hunziker, Michael O Kurrer, Gavin Y Oudit, Tania H Watts, Ivo Sonderegger, Kurt Bachmaier, Manfred Kopf, Josef M Penninger.   

Abstract

Genetic susceptibility and autoimmunity triggered by microbial infections are factors implicated in the pathogenesis of dilated cardiomyopathy, the most common cause of heart failure in young patients. Here we show that dendritic cells (DCs) loaded with a heart-specific self peptide induce CD4+ T-cell-mediated myocarditis in nontransgenic mice. Toll-like receptor (TLR) stimulation, in concert with CD40 triggering of self peptide-loaded dendritic cells, was shown to be required for disease induction. After resolution of acute myocarditis, DC-immunized mice developed heart failure, and TLR stimulation of these mice resulted in relapse of inflammatory infiltrates. Injection of damaged, syngeneic cardiomyocytes also induced myocarditis in mice if TLRs were activated in vivo. DC-induced myocarditis provides a unifying theory as to how tissue damage and activation of TLRs during infection can induce autoimmunity, relapses and cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625544     DOI: 10.1038/nm960

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  99 in total

Review 1.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.

Authors:  Raju V S R K Gottumukkala; HuiJuan Lv; Lizbeth Cornivelli; Amy J Wagers; Raymond Y Kwong; Roderick Bronson; Garrick C Stewart; P Christian Schulze; William Chutkow; Howard A Wolpert; Richard T Lee; Myra A Lipes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

Review 3.  Human dendritic cell subsets for vaccination.

Authors:  Peter Dubsky; Hideki Ueno; Bernard Piqueras; John Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

4.  NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.

Authors:  Rongbin Zhou; Haiming Wei; Rui Sun; Jian Zhang; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

Review 5.  Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Authors:  Patrick Blanco; A Karolina Palucka; Virginia Pascual; Jacques Banchereau
Journal:  Cytokine Growth Factor Rev       Date:  2008-02       Impact factor: 7.638

6.  CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells.

Authors:  Giandomenica Iezzi; Ivo Sonderegger; Franziska Ampenberger; Nicole Schmitz; Benjamin J Marsland; Manfred Kopf
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

Review 7.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

8.  The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.

Authors:  Michael M Reily; Carlos Pantoja; Xiaoyu Hu; Yurii Chinenov; Inez Rogatsky
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

Review 9.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity.

Authors:  Kajsa Wing; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 10.  Role of inflammation in the progression of heart failure.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Øie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.